Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes. [PDF]
Gomes RS +3 more
europepmc +1 more source
Hypermetabolic Pulmonary and Mediastinal Lesions With Elevated Cancer Antigen (CA) 15-3 and CA 27-29 in a Patient With a History of Ovarian and Breast Cancer. [PDF]
Venkatram S +5 more
europepmc +1 more source
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer. [PDF]
Nicolini A +6 more
europepmc +1 more source
An electrochemically synthesized molecularly imprinted polymer for highly selective detection of breast cancer biomarker CA 15-3: a promising point-of-care biosensor. [PDF]
Oliveira D +2 more
europepmc +1 more source
Antibody Biomimetic Material Made of Pyrrole for CA 15-3 and Its Application as Sensing Material in Ion-Selective Electrodes for Potentiometric Detection. [PDF]
Santos ART +3 more
europepmc +1 more source
Cáncer de mama en una paciente de 21 años
Se presenta el caso clínico de una paciente de 21 años de edad, quien acudió a la consulta de Oncología del Hospital Gubernamental de Mbabane en Suazilandia por presentar un nódulo en la mama derecha con manifestaciones de dolor intenso desde hacía 1 mes.
Ernesto Arias Beatón +3 more
doaj
Association of Dyslipidemia, Increased Insulin Resistance, and Serum CA 15-3 with Increased Risk of Breast Cancer in Urban Areas of North and Central India. [PDF]
Kachhawa P +5 more
europepmc +1 more source
Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions [PDF]
Saba MA +4 more
europepmc +1 more source
Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy. [PDF]
Nieder C +4 more
europepmc +1 more source
Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer. [PDF]
Geng B, Liang MM, Ye XB, Zhao WY.
europepmc +1 more source

